NCT02296411 - Efficacy of LAMA Added to ICS in Treatment of Asthma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Asthma

Interventions

DRUG

CHF 5259 12.5 µg

comparison of CHF5259 versus placebo over 2 treatment periods of 6 weeks

DRUG

CHF 5259 placebo

comparison of CHF5259 versus placebo over 2 treatment periods of 6 weeks

Trial Locations (28)

1000

Chiesi Clinical Trial Site 0101, Sofia

1336

Chiesi Clinical Trial Site 0109, Sofia

1407

Chiesi Clinical Trial Site 0108, Sofia

1431

Chiesi Clinical Trial Site 0102, Sofia

Chiesi Clinical Trial Site 0103, Sofia

5400

Chiesi Clinical Trial Site 0106, Sevlievo

7002

Chiesi Clinical Trial Site 0107, Rousse

25123

Chiesi Clinical Trial Site 0306, Brescia

33170

Chiesi Clinical Trial Site 0303, Pordenone

39112

Chiesi Clinical Trial Site 0206, Magdeburg

56124

Chiesi Clinical Trial Site 0301, Pisa

Chiesi Clinical Trial Site 0304, Pisa

58452

Chiesi Clinical Trial Site 0208, Witten

D-12165

Chiesi Clinical Trial Site 0201, Berlin

04207

Chiesi Clinical Trial Site 0203, Leipzig

04357

Chiesi Clinical Trial Site 0202, Leipzig

01445

Chiesi Clinical Trial Site 0207, Radebeul

9401 RK

Chiesi Clinical Trial Site 0404, Assen

5707 HA

Chiesi Clinical Trial Site 0405, Helmond

15-010

Chiesi Clinical Trial Site 0501, Bialystok

15-351

Chiesi Clinical Trial Site 0502, Bialystok

82-300

Chiesi Clinical Trial Site 0503, Elblag

30-349

Chiesi Clinical Trial Site 0507, Krakow

31-011

Chiesi Clinical Trial Site 0504, Krakow

90-141

Chiesi Clinical Trial Site 0512, Lodz

90-252

Chiesi Clinical Trial Site 0510, Lodz

53-310

Chiesi Clinical Trial Site 0505, Wroclaw

95-100

Chiesi Clinical Trial Site 0506, Zgierz

All Listed Sponsors

lead

Chiesi Farmaceutici S.p.A.

INDUSTRY